Keywords
diabetes mellitus type 2
relative telomere length
carbohydrate metabolism
How to Cite
Abstract
In 156 patients with stage II arterial hypertension, including 96 of them with diabetes mellitus type 2, the relationship between the relative telomeres length of blood leukocytes (RLTL) and buccal epithelium cells (RBTL) and different levels of carbohydrate metabolism have been determined and data in patients with arterial hypertension combined with diabetes mellitus type 2 and in patients with isolated hypertension have been compared. Carbohydrate metabolism parameters, blood pressure levels were evaluated. RLTL and RBTL were determined by a real time quantitative polymerase chain reaction. It is shown that a hypertension and diabetes mellitus type 2 combination was accompanied by greater significant RLTL (р=0.009) and RBTL (р=0.001) more than with isolated hypertension. In the patients with hypertension and diabetes mellitus type 2 the relative length of telomeres was assessed in the carbohydrate metabolism compensation and in its absence and no convincing data was obtained on the effect of glycemic control on the relative length of telomeres. In patients with isolated hypertension it was found that those with a lower glucose level than that within the risk factor (5.6–6.9 mmol/l) had a shorter mean relative telomeres length both of blood leukocytes (p=0.05) and the buccal epithelium cells (p=0.03) regarding indicators for those who had higher blood glucose levels. Patients with a comorbid course of hypertension and diabetes mellitus type 2 had more pronounced decrease in the RTL. Achieving glycemic control at hypertension and diabetes mellitus was accompanied by a significant increase in the RBTL. The relative length of blood leukocytes telomere was controversial. Additional determining the RBTL enhances the diagnostic and prognostic power when assessing the efficacy of correcting glycemic control in high cardiovascular risk patients.
References
Rizvi S., Raza S.T., Mahdi F. (2014). Telomere length variations in aging and age-related diseases. Curr. Aging Sci., № 7 (3), pp. 161–167.
Nicole C. Arsenis, Tongjian You, Elisa F. Ogawa, Grant M. Tinsley, Li Zuo (2017). Physical activity and telomere length: Impact of aging and potential mechanisms of action. Oncotarget, № 8 (27), pp. 45008–45019.
Harte A.L., da Silva N.F., Miller M.A., Cappuccio F.P., Kelly A., O'Hare J.P. et al. (2012). Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitus. Exp. Diabetes Res., № 2012, pp. 895185.
Zhiwei Yang, Xin Huang, Hong Jiang, Yanrong Zhang, Hongxia Liu, Chuan Qin et al. (2009). Short telomeres and prognosis of hypertension in a Chinese population. Hypertension, № 53 (4), pp. 639–645.
Fyhrquist F., Saijonmaa O., Strandberg T. (2013). The roles of senescence and telomere shortening in cardiovascular disease. Nat. Rev. Cardiol., № 10 (5), pp. 274–283.
Gadalla S.M., Cawthon R., Giri N., Alter B.P., Savage S.A. (2010). Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY), vol. 2, № 11, pp. 867–874.
Krasnenkov D.S., Loseva D.A., Koliada A.K., Kukharskii B.M., Makhii T.I., Vaiserman A.M., Ivasiuk M.R. (2015). Dlina telomer v bukkalnom epitelii u zhitelei raznoho vozrasta Kievskoi oblasti [Telomere length in the buccal epithelium of the Kiev region residents of different ages]. Problemy stareniia i dolholetiia – Problems of Aging and Longevity, vol. 24, № 2, pp. 111–119 [in Russian].
Mancia G., Fagard R., Narkiewicz K., Redón J., Zanchetti A., Böhm M. et al. (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. of Hypertension, № 31 (7), pp. 1281–1357.
Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M. et al. (2015). Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, vol. 38 (1), pp. 140–149.
Cawthon R.M. (2009). Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res., 2009, vol. 37 (3), e21.
Weischer M., Bojesen S.E., Cawthon R.M., Freiberg J.J., Tybjaerg-Hansen A., Nordestgaard B.G. (2012). Short telomere length, myocardial infarction, ischemic heart disease, and early death. Arterioscler. Thromb. Vasc. Biol., vol. 32 (3), pp. 822–829.
Bhupatiraju C., Saini D., Patkar S., Deepak P., Das B., Padma T. (2012). Association of shorter telomere length with essential hypertension in Indian population. Am. J. Hum. Biol., vol. 24 (4), pp. 573–578.
Grossman A., Grossman E. (2017). Blood pressure control in type 2 diabetic patients. Cardiovasc. Diabetol., vol. 16 (1), pp. 3.
Mengden T., Ligges U., Mielke J., Bramlage P., Korzinek A., Sehnert W. (2017). Blood pressure control and cardiovascular risk in hypertensive patients with type 2 diabetes: The German T2 Target registry. J. Clin. Hypertens. (Greenwich), vol. 19 (8), pp. 757–763.